Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension

Circ Res. 2009 Oct 23;105(9):886-96. doi: 10.1161/CIRCRESAHA.109.199018. Epub 2009 Sep 17.

Abstract

Rationale: Mitochondrial uncoupling proteins (UCPs) belong to a superfamily of mitochondrial anion transporters that uncouple ATP synthesis from oxidative phosphorylation and mitigates mitochondrial reactive oxygen species production.

Objective: We assessed the hypothesis that UCP2 participates in central cardiovascular regulation by maintaining reactive oxygen species homeostasis in the rostral ventrolateral medulla (RVLM), where sympathetic premotor neurons that maintain vasomotor tone located. We also elucidated the molecular mechanisms that underlie transcriptional upregulation of UCP2 in response to oxidative stress in RVLM.

Methods and results: In Sprague-Dawley rats, transcriptional upregulation of UCP2 in RVLM by rosiglitazone, an activator of its transcription factor peroxisome proliferator-activated receptor (PPAR)gamma, reduced mitochondrial hydrogen peroxide level in RVLM and systemic arterial pressure. Oxidative stress induced by microinjection of angiotensin II into RVLM augmented UCP2 mRNA or protein expression in RVLM, which was antagonized by comicroinjection of NADPH oxidase inhibitor (diphenyleneiodonium chloride), superoxide dismutase mimetic (tempol), or p38 mitogen-activated protein kinase inhibitor (SB203580) but not by extracellular signal-regulated kinase 1/2 inhibitor (U0126). Angiotensin II also induced phosphorylation of the PPARgamma coactivator, PPARgamma coactivator (PGC)-1alpha, and an increase in formation of PGC-1alpha/PPARgamma complexes in a p38 mitogen-activated protein kinase-dependent manner. Intracerebroventricular infusion of angiotensin II promoted an increase in mitochondrial hydrogen peroxide production in RVLM and chronic pressor response, which was potentiated by gene knockdown of UCP2 but blunted by rosiglitazone.

Conclusions: These results suggest that transcriptional upregulation of mitochondrial UCP2 in response to an elevation in superoxide plays an active role in feedback regulation of reactive oxygen species production in RVLM and neurogenic hypertension associated with chronic oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Angiotensin II / administration & dosage
  • Animals
  • Antioxidants / administration & dosage
  • Blood Pressure* / drug effects
  • Blood Pressure* / genetics
  • Blood Vessels / innervation*
  • Catalase / genetics
  • Catalase / metabolism
  • Cell Respiration
  • Cyclic N-Oxides / administration & dosage
  • Disease Models, Animal
  • Enzyme Inhibitors / administration & dosage
  • Homeostasis
  • Humans
  • Hydrogen Peroxide / metabolism
  • Hypertension / genetics
  • Hypertension / metabolism
  • Hypertension / physiopathology
  • Hypertension / prevention & control*
  • Imidazoles / administration & dosage
  • Ion Channels / genetics
  • Ion Channels / metabolism*
  • Male
  • Medulla Oblongata / drug effects
  • Medulla Oblongata / metabolism*
  • Microinjections
  • Mitochondria / metabolism
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism*
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism
  • Onium Compounds / administration & dosage
  • Oxidative Stress* / drug effects
  • PPAR gamma / agonists
  • PPAR gamma / metabolism
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Phosphorylation
  • Pyridines / administration & dosage
  • RNA-Binding Proteins / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Rosiglitazone
  • Spin Labels
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Superoxide Dismutase-1
  • Superoxides / metabolism
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism*
  • Sympathetic Nervous System / physiopathology
  • Thiazolidinediones / administration & dosage
  • Time Factors
  • Transcription Factors / metabolism
  • Transcriptional Activation* / drug effects
  • Transduction, Genetic
  • Uncoupling Protein 2
  • Up-Regulation
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Antioxidants
  • Cyclic N-Oxides
  • Enzyme Inhibitors
  • Imidazoles
  • Ion Channels
  • Mitochondrial Proteins
  • Onium Compounds
  • PPAR gamma
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Ppargc1a protein, rat
  • Pyridines
  • RNA-Binding Proteins
  • SOD1 protein, human
  • Spin Labels
  • Thiazolidinediones
  • Transcription Factors
  • UCP2 protein, human
  • Ucp2 protein, rat
  • Uncoupling Protein 2
  • Rosiglitazone
  • Superoxides
  • Angiotensin II
  • diphenyleneiodonium
  • Adenosine Triphosphate
  • Hydrogen Peroxide
  • Catalase
  • Sod1 protein, rat
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • superoxide dismutase 2
  • NADPH Oxidases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580
  • tempol